BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Dr Reddy's Aurigene Launches Drug Discovery Platform Aurigene.AI April 4, 2024 Aurigene.AI integrates AI and ML solutions with chemical design, synthesis, and bioassay assessment expertise to expedite novel therapeutics development.
Drug Discovery to Development: Gen AI and ML Can Transform Pharma Industry March 24, 2024 AI has also proven to be a valuable asset in both cancer research and the development of cancer drugs.
QIAGEN Launches AI-Driven Biomedical Knowledge Base to Propel Drug Discovery February 29, 2024 The knowledge base aids data scientists in comprehending disease mechanisms, identifying potential biomarkers, and exploring opportunities for drug repurposing.
Roche's Genentech Partners with NVIDIA for Accelerated Drug Discovery Through AI Collaboration November 24, 2023 Genentech and NVIDIA collaborate to optimise Genentech's ML algorithms on the NVIDIA DGX Cloud, a dedicated AI supercomputing platform with BioNemo for generative AI applications in drug discovery.
Germany-Based Merck Enters Two Strategic Collaborations to Strengthen AI-Driven Drug Discovery September 22, 2023 Germanys prominent science and technology player, Merck has entered into two strategic drug discovery collaborations with BenevolentAI, London, UK, and Exscientia, Oxford, UK.
Page 1 of 1
